{"id":"https://openalex.org/W4399690809","doi":"https://doi.org/10.2337/db24-1006-p","title":"1006-P: Continuous Glucose Monitoring for High-Risk Type 2 Diabetes in the Hospital\u2014The Cyber GEMS Randomized Controlled Trial Protocol","display_name":"1006-P: Continuous Glucose Monitoring for High-Risk Type 2 Diabetes in the Hospital\u2014The Cyber GEMS Randomized Controlled Trial Protocol","publication_year":2024,"publication_date":"2024-06-14","ids":{"openalex":"https://openalex.org/W4399690809","doi":"https://doi.org/10.2337/db24-1006-p"},"language":"en","primary_location":{"id":"doi:10.2337/db24-1006-p","doi":"https://doi.org/10.2337/db24-1006-p","is_oa":false,"landing_page_url":"https://doi.org/10.2337/db24-1006-p","pdf_url":null,"source":{"id":"https://openalex.org/S129060628","display_name":"Diabetes","issn_l":"0012-1797","issn":["0012-1797","1939-327X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5064853461","display_name":"Samantha R. Spierling Bagsic","orcid":"https://orcid.org/0000-0003-1274-3736","observed_orcids":["https://orcid.org/0000-0003-1274-3736"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"SAMANTHA R. SPIERLING BAGSIC","raw_affiliation_strings":["San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064894728","display_name":"Addie L. Fortmann","orcid":"https://orcid.org/0000-0002-0350-5288","observed_orcids":["https://orcid.org/0000-0002-0350-5288"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"ADDIE L. FORTMANN","raw_affiliation_strings":["San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075513541","display_name":"ALESSANDRA BASTIAN","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"ALESSANDRA BASTIAN","raw_affiliation_strings":["San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080694638","display_name":"Rebekah F. Belasco","orcid":"https://orcid.org/0000-0002-1499-4750","observed_orcids":["https://orcid.org/0000-0002-1499-4750"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"REBEKAH BELASCO","raw_affiliation_strings":["San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059628291","display_name":"Haley Sandoval","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"HALEY SANDOVAL","raw_affiliation_strings":["San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053561106","display_name":"Suzanne Lohnes","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"SUZANNE LOHNES","raw_affiliation_strings":["San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044399683","display_name":"Laura Mart\u00edn Talavera","orcid":"https://orcid.org/0000-0002-5250-007X","observed_orcids":["https://orcid.org/0000-0002-5250-007X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"LAURA TALAVERA","raw_affiliation_strings":["San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"San Diego, CA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5085399860","display_name":"Athena Philis\u2010Tsimikas","orcid":"https://orcid.org/0000-0002-3986-9630","observed_orcids":["https://orcid.org/0000-0002-3986-9630"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"ATHENA PHILIS-TSIMIKAS","raw_affiliation_strings":["San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"San Diego, CA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.1305079,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"73","issue":"Supplement_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11623","display_name":"Hyperglycemia and glycemic control in critically ill and hospitalized patients","score":0.8628000020980835,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11623","display_name":"Hyperglycemia and glycemic control in critically ill and hospitalized patients","score":0.8628000020980835,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.12720000743865967,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.00419999985024333,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/continuous-glucose-monitoring","display_name":"continuous glucose monitoring","score":0.9909999966621399},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9919999837875366},{"id":"https://openalex.org/keywords/hospitalized-patients","display_name":"hospitalized patients","score":0.781000018119812},{"id":"https://openalex.org/keywords/inpatient-glycemic-control","display_name":"inpatient glycemic control","score":0.6769999861717224},{"id":"https://openalex.org/keywords/point-of-care-glucose-testing","display_name":"point-of-care glucose testing","score":0.7229999899864197},{"id":"https://openalex.org/keywords/nosocomial-infections","display_name":"nosocomial infections","score":0.7210000157356262},{"id":"https://openalex.org/keywords/digital-health","display_name":"digital health","score":0.47600001096725464},{"id":"https://openalex.org/keywords/underserved-populations","display_name":"underserved populations","score":0.718999981880188},{"id":"https://openalex.org/keywords/subcutaneous-insulin","display_name":"subcutaneous insulin","score":0.6269999742507935},{"id":"https://openalex.org/keywords/disproportionate-share-hospitals","display_name":"disproportionate share hospitals","score":0.6320000290870667},{"id":"https://openalex.org/keywords/digital-dashboard","display_name":"digital dashboard","score":0.5879999995231628},{"id":"https://openalex.org/keywords/hyperglycemia","display_name":"hyperglycemia","score":0.5199999809265137}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7686665654182434},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.7316926121711731},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.6924905180931091},{"id":"https://openalex.org/C64841741","wikidata":"https://www.wikidata.org/wiki/Q491983","display_name":"Point-of-care testing","level":2,"score":0.6206806898117065},{"id":"https://openalex.org/C2986379492","wikidata":"https://www.wikidata.org/wiki/Q1638492","display_name":"Continuous glucose monitoring","level":4,"score":0.5605146288871765},{"id":"https://openalex.org/C2776217022","wikidata":"https://www.wikidata.org/wiki/Q1100933","display_name":"Diabetes management","level":4,"score":0.5569039583206177},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.4785119295120239},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.4740457534790039},{"id":"https://openalex.org/C2781232474","wikidata":"https://www.wikidata.org/wiki/Q124407","display_name":"Type 1 diabetes","level":3,"score":0.4694882035255432},{"id":"https://openalex.org/C2908918659","wikidata":"https://www.wikidata.org/wiki/Q4927806","display_name":"Blood Glucose Self-Monitoring","level":5,"score":0.4648752510547638},{"id":"https://openalex.org/C2780385302","wikidata":"https://www.wikidata.org/wiki/Q367158","display_name":"Protocol (science)","level":3,"score":0.42431530356407166},{"id":"https://openalex.org/C545542383","wikidata":"https://www.wikidata.org/wiki/Q2751242","display_name":"Medical emergency","level":1,"score":0.4226975440979004},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.3942442536354065},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.2744670510292053},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20241641998291016},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0820915699005127},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.2337/db24-1006-p","doi":"https://doi.org/10.2337/db24-1006-p","is_oa":false,"landing_page_url":"https://doi.org/10.2337/db24-1006-p","pdf_url":null,"source":{"id":"https://openalex.org/S129060628","display_name":"Diabetes","issn_l":"0012-1797","issn":["0012-1797","1939-327X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7170669958","https://openalex.org/W4407482618","https://openalex.org/W3164469103","https://openalex.org/W4380996596","https://openalex.org/W3120201466","https://openalex.org/W4313379745","https://openalex.org/W4397001545","https://openalex.org/W4399882686","https://openalex.org/W4400026294","https://openalex.org/W7116856244"],"abstract_inverted_index":{"Introduction":[0],"&":[1],"Objective:":[2],"Continuous":[3],"glucose":[4,87,142,152,250,302],"monitoring":[5,153,195],"(CGM)":[6],"for":[7,125,151,162,180,192,208,299,314],"inpatient":[8],"management":[9,127,182,303],"of":[10,140,217,232,251,263,296],"type":[11],"2":[12,67],"diabetes":[13,168],"(T2D)":[14],"has":[15],"been":[16],"supported":[17],"by":[18,25,165,183,196],"small":[19],"pilot":[20],"studies":[21],"but":[22],"lacks":[23],"confirmation":[24],"large":[26,68],"randomized":[27,133],"controlled":[28],"trials.":[29],"The":[30,91,104,283],"Cloud-Based":[31],"Real-Time":[32],"Glucose":[33],"Evaluation":[34],"and":[35,50,55,81,96,128,154,186,294,312],"Management":[36],"System":[37],"(Cyber":[38],"GEMS)":[39],"trial":[40],"tests":[41],"whether":[42],"real-time":[43,149,181,193,297],"CGM":[44,92,105,150,201,272,298,317],"can":[45],"improve":[46],"time":[47],"in,":[48],"above,":[49],"below":[51],"target":[52],"glycemic":[53],"range,":[54],"reduce":[56],"hospital":[57,301,315],"acquired":[58],"infections.":[59],"Methods:":[60],"This":[61],"in-progress":[62],"study":[63,278],"is":[64,94,160,178,190,202,287],"enrolling":[65],"at":[66,116],"disproportionate-share":[69],"hospitals":[70],"in":[71,112,119,204,276,304],"Southern":[72],"CA.":[73],"Eligible":[74],"patients":[75],"are":[76,132,225],"\u226518":[77],"years":[78,231],"with":[79,85,138,148],"T2D":[80,261,308],"on":[82,174],"subcutaneous":[83],"insulin":[84],"3+":[86],"\u2265":[88],"200":[89],"mg/dL.":[90],"device":[93],"placed":[95],"validated":[97],"against":[98],"POCT":[99],"using":[100],"the":[101,171,205,222,277,292],"%20/20":[102],"rule.":[103],"transmitter":[106],"sends":[107],"data":[108],"to":[109,123,134,258,290],"a":[110,113,166,175,187,197,305],"smartphone":[111],"lock":[114],"box":[115],"bedside":[117,184],"that,":[118],"turn,":[120],"transmits":[121],"values":[122],"platforms":[124],"clinical":[126,163],"evaluation":[129,210],"purposes.":[130],"Participants":[131,224,245],"usual":[135],"care":[136,141],"(UC)":[137],"point":[139],"testing":[143],"(POCT)":[144],"or":[145],"Cyber":[146,157,284],"GEMS":[147,285],"management.":[155],"In":[156],"GEMS,":[158],"CLARITY":[159],"used":[161,179,191],"optimization":[164],"remote":[167,198],"RN":[169],"specialist,":[170],"FOLLOW":[172],"app":[173],"unit":[176],"iPad":[177],"RN,":[185],"digital":[188],"dashboard":[189],"alert":[194],"team.":[199],"Blinded":[200],"utilized":[203],"UC":[206],"group":[207],"outcome":[209],"purposes":[211],"only.":[212],"Results:":[213],"N":[214],"=":[215,227,265],"209":[216],"554":[218],"participants":[219],"have":[220],"completed":[221],"study.":[223],"M":[226,264],"61.3":[228],"\u00b1":[229,254,267],"13.1":[230],"age,":[233],"59%":[234],"male,":[235],"75%":[236],"Hispanic;":[237],"58%":[238],"reported":[239],"an":[240,247,260],"annual":[241],"income":[242],"<":[243],"$20,000.":[244],"had":[246],"average":[248],"maximum":[249],"M:":[252],"315":[253],"80.6":[255],"mg/dL":[256],"prior":[257],"enrollment,":[259],"duration":[262,275],"17.3":[266],"12.1":[268],"years;":[269],"92%":[270],"were":[271],"naive.":[273],"Average":[274],"was":[279],"3.7":[280],"days.":[281],"Conclusion:":[282],"protocol":[286],"uniquely":[288],"designed":[289],"evaluate":[291],"value":[293],"utility":[295],"optimizing":[300],"high-risk,":[306],"underserved":[307],"population.":[309],"Lessons":[310],"learned":[311],"implications":[313],"based":[316],"use":[318],"will":[319],"be":[320],"presented.":[321],"Disclosure":[322],"S.R.":[323],"Spierling":[324],"Bagsic:":[325],"None.":[326,329,332,335,338,346],"A.L.":[327],"Fortmann:":[328],"A.":[330,347],"Bastian:":[331],"R.":[333],"Belasco:":[334],"H.":[336],"Sandoval:":[337],"S.":[339],"Lohnes:":[340],"Consultant;":[341],"Dexcom,":[342,351],"Inc.":[343,360],"L.":[344],"Talavera:":[345],"Philis-Tsimikas:":[348],"Advisory":[349],"Panel;":[350],"Inc.,":[352],"Lilly":[353],"Diabetes,":[354],"Novo":[355],"Nordisk,":[356],"Sanofi,":[357],"Medtronic,":[358],"Bayer":[359],"Funding":[361],"NIH":[362],"NIDDK":[363],"(1R01":[364],"DK124427-01A1)":[365]},"counts_by_year":[],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2024-06-15T00:00:00"}